¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"transmembrane channel"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • collateral channel
    °çÅë·Î
  • collector channel
    Áý°á°ü, Áý°á·Î
  • cation channel
    ¾çÀÌ¿ÂÅë·Î
  • calcium-channel blocker
    Ä®½·Åë·ÎÂ÷´ÜÁ¦
  • channel
    Åë·Î
  • channel block
    Åë·ÎÂ÷´Ü
  • fast channel
    ±Þ¼ÓÅë·Î
  • gated channel
    °ü¹®Åë·Î
  • ion channel disorder
    ÀÌ¿ÂÅë·ÎÁúȯ
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • voltage gated channel
    Àü¾ÐÀÛµ¿Åë·Î
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • channel
    Åë·Î
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • transmembrane potential
    ¸·ÀüÀ§, ¸·Àü¾Ð
  • transmembrane transport
    ¸·¿î¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transmembrane channel
    ¸·Åë·Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transmembrane potential difference
    ¸·ÀüÀ§Â÷ÀÌ
  • transmembrane potential
    ¸·ÀüÀ§, ¸·Àü¾Ð
  • transmembrane transport
    ¸·¿î¹Ý
  • channel block
    Åë·ÎÂ÷´Ü
  • channel
    Åë·Î
  • cation channel
    ¾çÀÌ¿ÂÅë·Î
  • collateral channel
    °çÅë·Î
  • collector channel
    Áý°á°ü, Áý°á·Î
  • fast channel
    ±Þ¼ÓÅë·Î
  • gated channel
    °ü¹®Åë·Î
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • voltage gated channel
    Àü¾ÐÀÛµ¿Åë·Î
  • parallel channel sign
    ÆòÇà°ü¡ÈÄ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fast channel
    ±Þ¼Ó(ÐááÜ)Åë·Î(÷×ÖØ)
  • T-type channel
    T-Çü Åë·Î
  • acetylcholine channel
    ¾Æ¼¼Æ¿Äݸ° Åë·Î
  • hepatocardiac channel
    °£½ÉÀå__ÊÜãýíôϵ).
  • porin channel
    Æ÷¸°Åë·Î
  • potassium channel
    Ä®·ýÅë·Î
  • pyloric channel
    À¯¹®Åë·Î.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transmembrane channel
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium channel blocker ; calcium channel blocking drug
    Ä®½·Åë·ÎºÀ¼â¾à ¹°<Á¦>, Ä®½·Åë·Î Â÷´Ü¾à¹°<Á¦>.
  • calcium channel blocker ; calcium channel blocking drug
    Ä®½·Åë·ÎºÀ¼â¾à¹°<Á¦>, Ä®½·Åë·ÎÂ÷´Ü¾à¹°<Á¦>.
  • transmembrane potential
    ¸·ÀüÀ§, ¸·Àü¾Ð
  • transmembrane potential
    ¸·ÀüÀ§.
  • transmembrane potential difference
    ¸·ÀüÀ§Â÷ÀÌ.
  • transmembrane transport
    ¸· Åë°ú À̵¿
  • acetylcholine channel
    ¾Æ¼¼Æ¿Äݸ° Åë·Î
  • calcium channel
    Ä®½·Åë·Î( -÷×ÖØ).
  • calcium channel
    Ä®½· Åë·Î(÷×ÖØ)
  • calcium channel antagonist,blocker
    Ä®½·Åë·Î ±æÇ×Á¦( -÷×ÖØ ÑÏù÷ð¥),Â÷´ÜÁ¦(ó´Ó¨ð¥).
  • cation channel
    ¾ç(åÕ)À̿ Åë·Î(÷×ÖØ)
  • channel
    Åë·Î.
  • channel
    Åë·Î(÷×ÖØ)
  • channel block
    Åë·ÎÂ÷´Ü
  • channel former
    Åë·ÎÇü¼º¹°Áú.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transmembrane potential
    ¸·È¾´ÜÀüÀ§(دüôÓ¨ï³êÈ)
  • transmembrane protein
    ¸·È¾´Ü ´Ü¹éÁú(دüôÓ¨Ó±ÛÜòõ)
  • channel
    "ä³Î, Åë·Î(÷×ÖØ)"
  • channel protein
    ä³Î ´Ü¹éÁú(Ó±ÛÜòõ)
  • gated channel
    °ü¹® Åë·Î (μڦ÷×ÖØ)
  • ion channel
    À̿ Åë·Î(÷×ÖØ)
  • ligand-gated channel
    ¸®°£µå °ü¹®Åë·Î(μڦ÷×ÖØ)
  • voltage-gated channel
    Àü¾Ð°³Æó(ï³äâËÒøÍ) Åë·Î(÷×ÖØ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • channel
    Åë·Î
  • collateral channel
    °çÅë·Î, ºÎÇà·Î
  • hepatocardiac channel
    °£½ÉÀ屸
  • lymph channel
    ¸²ÇÁ°ü
  • parallel channel sign
    ÆòÇà°ü¡ÈÄ
  • signal channel
    ½ÅÈ£Åë·Î
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TMP thiamine monophosphate; thymidine monophosphate; thymidine-5'-monophosphate; thymolphthalein monopho...
CFTR cystic fibrosis transmembrane conductance regulator
LESTR leukocyte-derived seven-transmembrane domain receptor
TAP transesophageal atrial pacing; transluminal angioplasty; transmembrane action potential; transporter...
TPG transmembrane potential gradient; transplacental gradient; tryptophan peptone glucose [broth]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
KATP channel ATP sensitive potassium channel
BK channel K channel
TM 6-transmembrane
CFTR CF transmembrane conductance regulator
CFTR Cystic Fibrosis Transmembrane Conductance Regulator
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • channel tray ºÐÇÒ º¹À§½Ä ¸ðÇüÀ» Á¦ÀÛÇÒ ¶§ »ç¿ëµÇ´Â ÇÃ¶ó½ºÆ½ ʹÝ. Dilok tray¿Í °°Àº ±â´ÉÀ» ÇÏ´Â °ÍÀÌ´Ù.

    channel-shoulder-pin attachment

    ¾¾ ¿¡½º ÇÇ ºÎ°¡ ÀåÄ¡
    Ä¡°ú ±â°ø½Ç¿¡¼­ Á¦ÀÛÇÒ ¼ö ÀÖ´Â °ÍÀ¸·Î °¢Á¾ Àΰø Ä¡°ú
  • transmembrane potential difference
    ¸·ÀüÀ§ Â÷ÀÌ
  • calcium channel
    Ä®½· ä³Î
    Ä®½·ÀÌ Åë°úÇÏ´Â µµ°ü.
  • calcium channel blocker
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°, Ä®½· ä³Î Â÷´ÜÁ¦
    µ¿ÀǾî=calcium channel blocking drug. 1. Ä®½·ÀÌ Åë°úÇÏ ´Â µµ°üÀ» ¸·´Â ¾à¹°. 2. Ç× Çù½ÉÁõ Á¦Á¦, Ç×°íÇ÷¾Ð Á¦Á¦, Ç× ºÎÁ¤¸Æ Á¦Á¦·Î »ç¿ëµÇ´Â ¾à¹°·Î½á, µ¿¸ÆÀÇ ÆòȰ±Ù¿¡¼­ Ä®½·ÀÇ À¯ÀÔÀ» Â÷´ÜÇÔÀ¸·Î½á ¸»ÃÊ ¼Òµ¿¸ÆÀ» ÀÌ¿ÏÇØ¼­ ½É±ÙÀÇ »ê¼Ò ¿ä±¸·®À» ÀúÇϽÃŰ´Â ±â´ÉÀ» ÇÑ´Ù. ´ëÇ¥ÀûÀÎ ¾à¹°·Î´Â, vera
  • calcium channel blocking drug
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°
  • calcium-channel blocker
    Ä®½· Â÷´ÜÁ¦, Ä®½· Åë·Î Â÷´ÜÁ¦
  • channel block
    Åë·Î Â÷´Ü
  • collateral channel
    °çÅë·Î, ºÎÇà·Î
  • ion channel
    À̿ Åë·Î
    ¼¼Æ÷¸· µî¿¡ Á¸ÀçÇϸç ÀÚ±ØÀÌ ¿À¸é Åë·Î¸¦ ¿­°í, ´ÝÀ½À¸·Î ÇØ¼­ ÀÌ¿ÂÀÇ ³óµµ¸¦ Á¶ÀýÇØ¼­ ÀÚ±ØÀÇ Àü´Þ¿¡ °ü¿©ÇÑ´Ù.
  • parallel channel sign
    ÆòÇà°ü ¡ÈÄ
  • sear channel teeth
    ½Ã¾î ä³Î µµÄ¡
    ºñÇØºÎÇÐÀû ÇüÅÂÀÇ µµÄ¡·Î¼­ ±³ÇÕ¸éÀº »ó, ÇÏ¾Ç ¸ðµÎ °ÅÀÇ ÆòźÇϰí ÇϾǿ¡¼­´Â ±Ù¿ø½ÉÀûÀ¸·Î ´Þ¸®´Â °¡´Â µ¹±â°¡ ÀÖÀ¸¸ç »ó¾Ç¿¡´Â À̰ÍÀÌ µé¾î°¡´Â ¾èÀº ±¸°¡ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cystic fibrosis transmembrane conductance regulator Gene believed to be defective in cystic fibrosis. Gene encodes a chloride channel, homologous to a family of proteins that actively transport small solutes in an ATP dependent manner (ABC transporters).
The regulator protein is a protein which is embedded in the cell membrane and acts as a channel for certain ions to be transported into or out of the cell. The disease cystic fibrosis is caused by a defect in the gene for this protein.
(09 Oct 1997)
hepatoma transmembrane kinase <enzyme> A transmembrane tyrosine kinase of the eph subfamily; genbank u07695
Registry number: EC 2.7.1.-
Synonym: htk protein, htk gene product
(26 Jun 1999)
transmembrane Through or across a membrane.
(05 Mar 2000)
transmembrane potential <physiology> More correctly, transmembrane potential difference: the electrical potential difference across a plasma membrane.
See: resting potential, action potential.
(18 Nov 1997)
transmembrane protein <cell biology> A protein subunit in which the polypeptide chain is exposed on both sides of the membrane. The term does not apply when different subunits of protein complex are exposed at opposite surfaces. most integral membrane proteins are also transmembrane proteins.
(13 Nov 1997)
transmembrane transducer A system that transmits a chemical or electrical signal across a membrane. Usually involves a transmembrane receptor protein that is thought to undergo a conformation change that is expressed on the inner surface of the membrane. Many such transducing species are dimeric and the conformation change may involve interaction between the two components.
(18 Nov 1997)
calcium channel <physiology> A membrane channel that is specific for calcium. It is a voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorised as l, t, n, or p types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins.
(12 May 2002)
calcium channel agonist <pharmacology> Agents that increase calcium influx into calcium channels of excitable tissues.
This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.
(12 Dec 1998)
calcium channel antagonist <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools.
Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.
Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent.
(12 May 2002)
calcium channel-blocker <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools.
Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.
Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent.
(12 May 2002)
gated ion channel <physiology> Transmembrane proteins of excitable cells, that allow a flux of ions to pass only under defined circumstances. Channels may be either voltage gated, such as the sodium channel of neurons or ligand gated such as the acetylcholine receptor of cholinergic synapses. Channels tend to be relatively ion specific and allow fluxes of typically 1000 ions to pass in around 1ms, they are thus much faster at moving ions across a membrane than transport ATPases.
(05 May 1997)
voltage-gated channel A class of ion channel's that open and close in response to change in the electrical potential across the plasma membrane of the cell; voltage-gated Na+ c.'s are important for conducting action potential along nerve cell processes.
(05 Mar 2000)
voltage gated ion channel <physiology> A transmembrane ion channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. These channels are essential for neuronal signal transmission and for intracellular signal transduction.
See: sodium channel.
(18 Nov 1997)
channel A furrow, gutter, or groovelike passageway.
See: canal.
Origin: L. Canalis
(05 Mar 2000)
channel forming ionophore <chemistry> An ionophore that makes an amphipathic pore with hydrophobic exterior and hydrophilic interior. most known types are cation selective.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • channel
    ¼ö·Î
  • Channel Islands
    ÇØÇùÁ¦µµ(ÇÁ¶û½º ºÏ¼­ºÎÀÇ ¿µ·ÉÀÇ ¼¶)
  • English Channel
    ¿µ±¹ ÇØÇù
  • North Channel
    ³ë½º ÇØÇùÄÚÆ²·£µå¿Í ºÏ¾ÆÀÏ·£µå »çÀÌ)
  • channel
    ÇöÃø°è·ùÆÇ(µÀ´ëÀÇ ¹öÆÀÁÙÀ» ¸É)
  • channel
    °­¹Ù´Ú;ÇÏ»ó;À¯»ó;¼ö·Î;°¡Ç×¼ö·Î;¿îÇÏ;ÇØÇù;(º¸µµ,¹«¿ª µîÀÇ)°æ·Î;·çÆ®;°èÅë;(Á¤½Ä)Àü´Þ ·çÆ®;(¿Õº¹ µîÀÇ)°æ·Î;(¶óµð¿À.ÅÚ·¹ºñÀü µîÀÇ)ä³Î;(ÇÒ´çµÈ)Á֯ļö´ë;(»ç»ó.Çൿ µîÀÇ)¹æÇâ;¹æÄ§;(Ȱµ¿ÀÇ)ºÐ¾ß;(µµ·ÎÀÇ)µµ¶û;Ãø±¸;¾Ï°Å;¼Ò°ü;µµ°ü;(¹®Áö¹æ µîÀÇ Àå½ÄȨ,(ÀϹÝÀûÀ¸·Î) °¡
  • channel iron (bar)
    Ȩ¼è(UÀÚ ¸ð¾çÀÇ ¼â.¸ø) a
  • channel lease
    ä³Î¸®½º(À¯¼± TVÀÇ ºó ä³ÎÀÇ ´ë¿©(Â÷¿ë))
  • channel separation
    ä³ÎºÐ¸®
  • channel(l)ed
    ȨÀÌ ÀÖ´Â
  • cross-channel
    ÇØÇùȾ´ÜÀÇ;ÇØÇùÀÇ ¸ÂÀº Æí ÂÊÀÇ(ƯÈ÷ ¿µ±¹ ÇØÇùÀÇ)
  • idiot channel
    ¹Î°£ ÅÚ·¹ºñÁ¯ ¹æ¼Û
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á